According to the Philippine Statistics Authority, cancer cases in the Philippines continue to rise each year, which is why it remains one of the top health illnesses that Filipinos are most worried about. Many cases are still diagnosed at later stages when treatment becomes more challenging.
As healthcare costs grow and access to timely care becomes even more essential, staying proactive about your health matters more than ever. Early detection empowers individuals to make informed decisions and take action sooner—supporting better long‑term wellness.
Medical innovations have made early cancer screening accessible, precise, and reliable. At Manulife, we make that progress work harder for you.
We have partnered with trusted health institutions to provide our customers convenient access to cancer screening programs designed to support early detection, quality care, and better health outcomes, complemented by resources that deepen their understanding of their health.
Through these efforts, our customers can stay proactive, informed, and one step ahead—making every MOVE count for today and tomorrow.
The Healthway Medical Network, under AC Health, is one of the Philippines’ rapidly growing healthcare provider networks, offering accessible and high quality medical services across the country. Its network includes multi specialty clinics, ambulatory centers, and hospitals designed to provide comprehensive and patient centered care.
Among its key institutions is Healthway Cancer Care Hospital (HCCH), the Philippines’ first dedicated comprehensive cancer hospital. HCCH delivers the full spectrum of cancer services from screening and diagnosis to advanced treatment and survivorship care through its Centers of Excellence - multidisciplinary team of specialists and a complete suite of oncology technologies. Through its network of local and international partnerships, patients receive world-class cancer care and can even access second opinion consultations and advance treatments from partner institutions.
Established in 2015, AC Health has grown into one of the country’s most dynamic healthcare platforms, integrating healthcare providers and pharmaceutical services to support better health outcomes for Filipinos. Through Healthway Medical Network and its pharmaceutical partners including Generika Drugstore, IE Medica and MedEthix, AC Health works to strengthen access to quality healthcare across the nation.
Visit these websites to learn more about them:
Guardant Health AMEA is a wholly owned subsidiary of Guardant Health, a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, we're transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer.
Manulife has partnered with Guardant Health, Inc., becoming the first insurer in Asia to offer Guardant Health’s Shield Multi-Cancer Detection (MCD) test to customers in Hong Kong, the Philippines, and Singapore. Under the partnership, Manulife's customers will have exclusive access to the Shield MCD test in these three launch markets in 2026, marking the first introduction of this innovative test in Asia to Manulife customers. This collaboration underscores both companies’ shared commitment to expanding access to innovative and proven health solutions that address real, unmet health needs.
Manulife Philippines is regulated by the Philippine Insurance Commission and is authorized to provide financial products or services in the Philippines.
Copyright © 2020, The Manufacturers Life Insurance Company and its subsidiaries. All rights reserved. Main office: 10th Floor NEX Tower, 6786 Ayala Avenue, Makati City, 1229 Tel : +632 8884 7000, Toll-free: 1-800-1-888-6268
